期刊
NUCLEIC ACIDS RESEARCH
卷 50, 期 14, 页码 8107-8126出版社
OXFORD UNIV PRESS
DOI: 10.1093/nar/gkac618
关键词
-
资金
- Ionis Pharmaceuticals, Inc.
- Ionis Pharaceuticals
Non-CpG PS-ASOs can activate the innate immune system, but may lead to undesired outcomes. The innate immune responses of PS-ASOs can vary depending on their modifications and sequence. Pro-inflammatory PS-ASOs require TLR9 signaling, but their innate immunity is not correlated with their binding affinity with TLR9. Additionally, non-inflammatory PS-ASOs can reduce the innate immune responses of pro-inflammatory PS-ASOs, suggesting interaction with TLR9.
Non-CpG PS-ASOs can activate the innate immune system, leading to undesired outcomes. This response can vary-in part-as a function of 2 ' modifications and sequence. Here we investigated the molecular steps involved in the varied effects of PS-ASOs on the innate immune system. We found that pro-inflammatory PS-ASOs require TLR9 signaling based on the experimental systems used. However, the innate immunity of PS-ASOs does not correlate with their binding affinity with TLR9. Furthermore, the innate immune responses of pro-inflammatory PS-ASOs were reduced by coincubation with non-inflammatory PS-ASOs, suggesting that both pro-inflammatory and non-inflammatory PS-ASOs can interact with TLR9. We show that the kinetics of the PS-ASO innate immune responses can vary, which we speculate may be due to the existence of alternative PS-ASO binding sites on TLR9, leading to full, partial, or no activation of the pathway. In addition, we found that several extracellular proteins, including HMGB1, S100A8 and HRG, enhance the innate immune responses of PS-ASOs. Reduction of the binding affinity by reducing the PS content of PS-ASOs decreased innate immune responses, suggesting that PS-ASO-protein complexes may be sensed by TLR9. These findings thus provide critical information concerning how PS-ASOs can interact with and activate TLR9.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据